Forward Bio
Turnover is estimated at about €210,000, probably between €180,000 and €240,000. The micro format does not state turnover.
Balance sheet
balance sheet total €287,166 on 30-06-2025in euro
in euro
Position in the sector
80.6%
Higher than 78% of the 41,316 companies filing micro accounts in head offices and management consultancy (NACE 70) in 2025.
5.24
Higher than 79% of the 39,879 companies filing micro accounts in head offices and management consultancy (NACE 70) in 2025.
30.3%
Higher than 72% of the 40,402 companies filing micro accounts in head offices and management consultancy (NACE 70) in 2025.
Net result: top quarter · Equity: top quarter · Balance sheet total: middle half · Working capital: top quarter
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 202416 months |
|---|---|---|---|
| 124,990 | 212,757 | ||
| 89,728 | 150,092 | ||
| 2,223 | 10,621 | ||
| 57,490 | - | ||
| 228,510 | 144,119 | ||
| 80.6% | 63.8% | ||
| 5.24 | 2.81 | ||
| 0.24 | 0.57 | ||
| 37.6% | 99.1% | ||
| 30.3% | 63.2% | ||
| over 100 | over 100 |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 202416 months |
|---|---|---|---|
| Balance sheet: assets | |||
20/58 |
287,166 | 229,001 | |
21/28 |
4,756 | 5,257 | |
22/27 |
4,356 | 4,857 | |
24 |
4,356 | 4,857 | |
28 |
400 | 400 | |
29/58 |
282,410 | 223,744 | |
40/41 |
25,883 | 24,565 | |
40 |
25,883 | 24,565 | |
54/58 |
255,596 | 198,105 | |
490/1 |
932 | 1,074 | |
| Balance sheet: equity and liabilities | |||
10/49 |
287,166 | 229,001 | |
10/15 |
231,401 | 146,062 | |
10/11 |
3,000 | 3,000 | |
13 |
228,401 | 143,062 | |
133 |
228,401 | 143,062 | |
17/49 |
55,765 | 82,939 | |
42/48 |
53,900 | 79,625 | |
44 |
4,281 | 2,003 | |
440/4 |
4,281 | 2,003 | |
45 |
44,143 | 73,647 | |
450/3 |
44,143 | 73,647 | |
47/48 |
5,475 | 3,974 | |
492/3 |
1,866 | 3,314 | |
| Income statement | |||
9900 |
125,134 | 212,757 | |
630 |
2,724 | 5,364 | |
640/8 |
144 | - | |
9901 |
122,266 | 207,392 | |
75/76B |
0 | 5 | |
75 |
0 | 5 | |
65/66B |
606 | 503 | |
65 |
606 | 503 | |
9903 |
121,661 | 206,894 | |
67/77 |
34,656 | 62,166 | |
9904 |
87,005 | 144,728 | |
9905 |
87,005 | 144,728 | |
| Appropriation of the result | |||
9906 |
87,005 | 144,728 | |
691/2 |
85,339 | 143,062 | |
6921 |
85,339 | 143,062 | |
694/7 |
1,666 | 1,666 | |
694 |
1,666 | 1,666 | |
| Document | |||
The full notes are in the filed accounts (PDF).
Source: Annual accounts 2025 (PDF), filed on 05-01-2026.
Filings
each dot is a set of accounts, on the day it reached the National BankInvestments
fixed assets acquired| Item | 30-06-2025 | 30-06-2024 |
|---|---|---|
| Tangible fixed assets | €2,223 | €10,221 |
| Financial fixed assets | - | €400 |
| €2,724 | €5,364 |
Source: notes to the 2024 to 2025 annual accounts (statement of fixed assets)
Insights on Forward Bio
Debt's share of the balance-sheet total falls from 36.2% to 19.4%. Equity is higher and debt is lower.